Stent Thrombosis in Patients With Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial

Circulation. 2020 Mar 3;141(9):781-783. doi: 10.1161/CIRCULATIONAHA.119.044584. Epub 2019 Nov 11.

¹ Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.D.L., D.M.W., L.T., C.B.G., J.H.A.).
² University of Pavia and Fondazione IRCCS Policlinico S. Matteo, Italy (S.L.).
³ UPMC Pinnacle, Harrisburg, PA (A.N.V.).
⁴ University of Sheffield, UK (R.F.S.).
⁵ University of Medicine and Pharmacy Carol Davila, University and Emergency Hospital of Bucharest, Romania (D.V.).
⁶ Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada (S.G.G.).
⁷ Terrence Donnelly Heart Centre, St Michael's Hospital, University of Toronto, ON, Canada (S.G.G.).
⁸ Bristol-Myers Squibb, Lawrenceville, NJ (R.A.).
⁹ Bern University Hospital, Inselspital, University of Bern, Switzerland (S.W., M.V.).
¹⁰ Heart Center Leipzig at the University of Leipzig, Department of Internal Medicine/Cardiology and Leipzig Heart Institute, Germany (H.T.).
¹¹ Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, and Cardiovascular Research Foundation, New York (R.M.).

No abstract available

Keywords: anticoagulants; atrial fibrillation; coronary artery disease; percutaneous coronary intervention; stents; thrombosis.

Publication types